LipidCurious Podcast Por Vishnu Priya Pulipati MD FACE DipABCL arte de portada

LipidCurious

LipidCurious

De: Vishnu Priya Pulipati MD FACE DipABCL
Escúchala gratis

Podcast dedicated to demystifying lipids for medical boards and real-world clinical practice.

© 2026 LipidCurious
Episodios
  • A Simple 3-Step Way to Approach the 2026 Multisociety Dyslipidemia (or Any) Guideline
    Mar 27 2026

    What do you do when a 100+ page evidence-rich guideline drops?

    Most of us intend to read it, save it for later… and never really use it effectively. Not because we do not care, but because we were never taught how to read them.

    In this episode, we take a different approach. Using the recently published 2026 multisociety dyslipidemia guideline as an example, and drawing from my experience as a guideline co-author, we focus on how to read and apply any guideline without getting overwhelmed.

    I walk through a simple 3-step framework to break down dense guidelines and turn them into practical clinical decisions.

    Guidelines do not change practice. How we use them does.

    Disclaimer: This podcast is intended for educational purposes for clinicians and healthcare professionals. It does not provide medical advice, establish a physician–patient relationship, or replace individualized clinical judgment. The opinions expressed are those of the creator and do not represent the views of any affiliated institutions or organizations.

    Más Menos
    10 m
  • Statins Beyond LDL-C: Pleiotropy, Special populations, & Why They Still Matter
    Mar 13 2026

    Let’s talk about statins. I know… boring, right? Most of us already know a lot about them. But thinking of statins only as cholesterol drugs misses the bigger picture.

    In many ways, statins are best understood as anti-atherosclerotic therapies that modify plaque biology, vascular inflammation, and cardiovascular risk far beyond simple LDL reduction.

    In this episode, we cover:

    1. Pleiotropic effects of statins beyond LDL-C lowering
    2. Choosing the right statin in special populations
    3. Why statins remain foundational therapy even in the era of newer lipid-lowering drugs

    Whether you prescribe statins daily or want a deeper understanding of why they work so well, this episode revisits the science behind one of the most important therapies in preventive cardiology.

    Bonus: Visual guide to help you navigate the episode.

    Want a companion resource? Download the free LipidCurious Starter Kit here
    Questions or feedback? hello@lipidcurious.com

    Join the Learn at Pinnacle app ⁠to earn FREE CE Credit for listening to this episode!

    Disclaimer: This podcast is intended for educational purposes for clinicians and healthcare professionals. It does not provide medical advice, establish a physician–patient relationship, or replace individualized clinical judgment. The opinions expressed are those of the creator and do not represent the views of any affiliated institutions or organizations.

    Más Menos
    16 m
  • LipidCurious Inspiration: Dr.Thomas Dayspring
    Feb 27 2026

    In this special LipidCurious Inspiration episode, Dr. Vishnu Priya Pulipati, MD, FACE, DiplABCL, sits down with legendary lipid educator Dr. Thomas Dayspring, MD, FACP, FNLA, for a conversation beyond guidelines and numbers. Together, they explore the personal stories, career pivots, and defining moments that shaped a five-decade journey in medicine and lipidology. From evolving clinical passions to the power of teaching and lifelong curiosity, this episode is a reflective look at sustaining purpose and inspiration in a long career, especially when the spark needs reigniting.

    Download the free LipidCurious Starter Kit here
    Questions or feedback? hello@lipidcurious.com

    Disclaimer: This podcast is intended for educational purposes for clinicians and healthcare professionals. It does not provide medical advice, establish a physician–patient relationship, or replace individualized clinical judgment. The opinions expressed are those of the creator and do not represent the views of any affiliated institutions or organizations.

    Más Menos
    14 m
Todavía no hay opiniones